SPIRIT 2013 Statement: Defining Standard Protocol Items for Clinical Trials
Annals of Internal MedicinePublished 5 February 2013Open access
An‐Wen Chan, Jennifer Tetzlaff, Douglas G. Altman, Andreas Laupacis, Peter C Gøtzsche, Karmela Krleža-Jerić
Citations7,982
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
The systematic development and scope of SPIRIT (Standard Protocol Items: Recommendations for Interventional Trials) 2013 is described, a guideline for the minimum content of a clinical trial protocol.
Abstract
The protocol of a clinical trial serves as the foundation for study planning, conduct, reporting, and appraisal. However, trial protocols and existing protocol guidelines vary greatly in content and quality. This article describes the systematic development and scope of SPIRIT (Standard Protocol Items: Recommendations for Interventional Trials) 2013, a guideline for the minimum content of a clinical trial protocol.The 33-item SPIRIT checklist applies to protocols for all clinical trials and focuses on content rather than format. The checklist recommends a full description of what is planned; it does not prescribe how to design or conduct a trial. By providing guidance for key content, the SPIRIT recommendations aim to facilitate the drafting of high-quality protocols. Adherence to SPIRIT would also enhance the transparency and completeness of trial protocols for the benefit of investigators, trial participants, patients, sponsors, funders, research ethics committees or institutional review boards, peer reviewers, journals, trial registries, policymakers, regulators, and other key stakeholders.
Keywords
Decision SciencesMathematicsEconomics, Econometrics and Finance
BMC MedicineCONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
13,537 Citations2010the CONSORT Group, Kenneth F. Schulz +2 more
BMJSPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
7,062 Citations2013A.-W. Chan, Jennifer Tetzlaff +11 more
The SPIRIT 2013 Explanation and Elaboration paper provides important information to promote full understanding of the checklist recommendations and strongly recommends that this explanatory paper be used in conjunction with the SPIRit Statement.
Annals of Internal MedicineCONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomized Trials
3,864 Citations2010Kenneth F. Schulz, Douglas G. Altman +2 more
The latest version of the CONSORT statement, CONSORT 2010, is described, which updates the reporting guideline based on new methodological evidence and accumulating experience.
JAMAEmpirical Evidence for Selective Reporting of Outcomes in Randomized Trials
1,806 Citations2004An‐Wen Chan, Asbjørn Hróbjartsson +3 more
The reporting of trial outcomes is not only frequently incomplete but also biased and inconsistent with protocols and Published articles, as well as reviews that incorporate them, may therefore be unreliable and overestimate the benefits of an intervention.
PLoS ONESystematic Review of the Empirical Evidence of Study Publication Bias and Outcome Reporting Bias
1,506 Citations2008Kerry Dwan, Douglas G. Altman +12 more
There is strong evidence of an association between significant results and publication; studies that report positive or significant results are more likely to be published and outcomes that are statistically significant have higher odds of being fully reported.
PLoS MedicineGuidance for Developers of Health Research Reporting Guidelines
1,380 Citations2010David Moher, Kenneth F. Schulz +2 more
David Moher and colleagues from the EQUATOR network offer guidance and recommended steps for developing health research reporting guidelines.
Systematic ReviewsDoes use of the CONSORT Statement impact the completeness of reporting of randomised controlled trials published in medical journals? A Cochrane reviewa
629 Citations2012Lucy Turner, Larissa Shamseer +3 more
It is suggested that journal endorsement of CONSORT may benefit the completeness of reporting of RCTs they publish, and between endorsing and non-endorsing journals, 25 outcomes are improved with CONSORT endorsement, five of these significantly.
PubMedICH Harmonised Tripartite Guideline: Guideline for Good Clinical Practice.
531 Citations2002P. S. Bhuiyan, N. N. Rege
BMJThe quality of reports of randomised trials in 2000 and 2006: comparative study of articles indexed in PubMed
505 Citations2010Sally Hopewell, Susan Dutton +3 more
Reporting of several important aspects of trial methods improved between 2000 and 2006; however, the quality of reporting remains well below an acceptable level.
New England Journal of MedicineClinical Trial Registration — Looking Back and Moving Ahead
323 Citations2007Christine Lainé, Richard Horton +13 more
PLoS MedicineGhost Authorship in Industry-Initiated Randomised Trials
286 Citations2007Peter C Gøtzsche, Asbjørn Hróbjartsson +4 more
Ghost authorship in industry-initiated trials is very common and its prevalence could be considerably reduced, and transparency improved, if existing guidelines were followed, and if protocols were publicly available.
Cochrane Database of Systematic ReviewsComparison of protocols and registry entries to published reports for randomised controlled trials
240 Citations2011Kerry Dwan, Douglas G. Altman +4 more
To systematically review studies of cohorts of RCTs to compare the content of trial reports with the information contained in their protocols, or entries in a trial registry, the quality and extent of information included in trial registries is improved and trialists explain substantial changes in their reports.
BMJPrinciples for international registration of protocol information and results from human trials of health related interventions: Ottawa statement (part 1)
239 Citations2005Karmela Krleža-Jerić, An‐Wen Chan +4 more
An open meeting on 4 October 2004 in Ottawa, Canada, to foster international consensus on trial registration aims to establish internationally recognised principles for registration and highlights and discusses some of the key principles.
BMJFrequency and reasons for outcome reporting bias in clinical trials: interviews with trialists
220 Citations2011Rebecca MD Smyth, Jamie J Kirkham +4 more
The prevalence of incomplete outcome reporting is high and affects trial design, conduct, analysis, and reporting and a general lack of consensus regarding the choice of outcomes in particular clinical settings was evident.
BMJComparison of descriptions of allocation concealment in trial protocols and the published reports: cohort study
208 Citations2005Julie Pildal, An‐Wen Chan +4 more
Most randomised clinical trials have unclear allocation concealment on the basis of the trial publication alone, and most of these trials also have unclear allocations concealment according to their protocol.
BMJDiscrepancies in sample size calculations and data analyses reported in randomised trials: comparison of publications with protocols
198 Citations2008A.-W. Chan, A. Hrobjartsson +3 more
To evaluate how often sample size calculations and methods of statistical analysis are pre-specified or changed in randomised trials, protocols and journal publications initially approved in 1994-5 by the scientific-ethics committees for Copenhagen and Frederiksberg were evaluated.
The LancetClinical trial registration: transparency is the watchword
163 Citations2006Ida Sim, An‐Wen Chan +3 more
The LancetThe Good Clinical Practice guideline: a bronze standard for clinical research
162 Citations2005David A. Grimes, David Hubacher +4 more
National Academies Press eBooksA National Cancer Clinical Trials System for the 21st Century
134 Citations2010Board on Health Care Services
BMJImpact of document type on reporting quality of clinical drug trials: a comparison of registry reports, clinical study reports, and journal publications
129 Citations2012Beate Wieseler, M Kerekeş +3 more
The LancetSelective reporting in clinical trials: analysis of trial protocols accepted by The Lancet
117 Citations2008Sanaa Al-Marzouki, Ian Roberts +2 more
Journal of Clinical OncologyAdverse Event Reporting in Publications Compared With Sponsor Database for Cancer Clinical Trials
106 Citations2006Orit Scharf, A. Dimitrios Colevas
Lack of consistency in and reporting of AEs are associated with NCI database and trial publication AE data discrepancy.
Journal of Clinical EpidemiologyPublished methodological quality of randomized controlled trials does not reflect the actual quality assessed in protocols
100 Citations2012Rahul Mhaskar, Benjamin Djulbegović +3 more
The largest study to date shows that poor quality of reporting does not reflect the actual high methodological quality of RCTs, and actual quality assessment showed no association between ES and methodological quality.
JAMAConstraints on Publication Rights in Industry-Initiated Clinical Trials
79 Citations2006Peter C Gøtzsche, Asbjørn Hróbjartsson +4 more
Systematic ReviewsGuidelines for randomized clinical trial protocol content: a systematic review
77 Citations2012Jennifer Tetzlaff, An‐Wen Chan +4 more
A systematically developed, evidence-informed guideline for clinical trial protocols is needed, as existing guidelines for RCT protocol content varied substantially in their recommendations.
Drug Information JournalMeasuring the Incidence, Causes, and Repercussions of Protocol Amendments
77 Citations2011Kenneth Getz, Rachael B. Zuckerman +4 more
It was found that more than 40% of protocols were amended prior to the first subject/first visit, and one third of amendments were avoidable, underscore the substantial impact of protocol amendments on drug development efficiency and present an opportunity to realize substantial cycle time and cost savings.
TrialsDeveloping a guideline for clinical trial protocol content: Delphi consensus survey
72 Citations2012Jennifer Tetzlaff, David Moher +1 more
This Delphi process achieved consensus from a large panel of experts from diverse stakeholder groups on essential content for RCT protocols, helping guide the development of a guideline for protocol content.
BMJOut of sight but not out of mind: how to search for unpublished clinical trial evidence
62 Citations2012A.-W. Chan
An-Wen Chan provides guidance for reviewers on adopting a comprehensive strategy to search beyond the published literature in order to identify the existence and results of unpublished trials.
PLoS MedicineA Taxpayer-Funded Clinical Trials Registry and Results Database
55 Citations2004Erick H. Turner
Journal of Clinical EpidemiologyReporting on blinding in trial protocols and corresponding publications was often inadequate but rarely contradictory
53 Citations2009Asbjørn Hróbjartsson, Julie Pildal +4 more
The reporting on blinding in both trial protocols and publications is often inadequate and it is suggested that international guidelines for the reporting oftrial protocols and public access to protocols should be developed.
Annals of Internal MedicineClinical Trial Registration: Looking Back and Moving Ahead
52 Citations2007Christine Lainé, Catherine De Angelis +13 more
NeurosurgerySubgroup Analysis and Covariate Adjustment in Randomized Clinical Trials of Traumatic Brain Injury: A Systematic Review
50 Citations2005Adrían V. Hernández, Ewout W. Steyerberg +4 more
The reported covariate adjustment and subgroup analyses from TBI trials had several methodological shortcomings and should be considerably improved in future TBI Trials because interpretation of treatment benefits may be misleading otherwise.
PLoS ONEReporting of Methodologic Information on Trial Registries for Quality Assessment: A Study of Trial Records Retrieved from the WHO Search Portal
47 Citations2010Ludovic Revéiz, An‐Wen Chan +8 more
In order to permit adequate critical appraisal of trial results reported in journals and registries, trial registries should consider requesting details on key RCT methods to complement journal publications.
BMJTrial protocols at the <i>BMJ</i>
32 Citations2004Giselle Jones, Kamran Abbasi
Authors must submit the protocol with the trial and provide evidence that the protocol can be applied in the context of clinical trials.
JAMARegistering Clinical Trial Results
31 Citations2010James Dabney Miller
The NIH is currently developing this regulation, which will be the important next step in the registration of clinical trials and an important opportunity for the NIH to improve the quality and reliability of clinical research of drugs.
The LancetProtocols, probity, and publication
30 Citations2009William Summerskill, David Collingridge +1 more
This chapter discusses salt reduction and cardiovascular risk: the anatomy of a myth, which aims to explain why low urinary sodium is associated with greater risk of mycardial infarction among treated hypertensive men.
TrialsLead editorial: Trials – using the opportunities of electronic publishing to improve the reporting of randomised trials
30 Citations2006Douglas G. Altman, Curt D. Furberg +2 more
The new online, open access, peer-reviewed journal Trials is introduced, which considers manuscripts on any aspect of the design, performance, and findings of randomised controlled trials in any discipline related to health care, and also encourages the publication of protocols.
The LancetAccess to data in industry-sponsored trials
26 Citations2011Andreas Lundh, Helle Terkildsen Maindal +1 more
The LancetStrengthening the credibility of clinical research
24 Citations2010Catherine D. DeAngelis, Phil Fontanarosa
The Lancet editors and the editors of other medical journals are urged to take the next logical and essential step to strengthen the credibility of industry-sponsored medical research, to require that all industrysponsored studies have the data analysed by an independent academic biostatistician or researcher who has full access to all study data.
Proceedings of the American Thoracic SocietyEthical Considerations in the Interpretation and Communication of Clinical Trial Results
20 Citations2007David Coultas
The objective of this article is to raise awareness among the pulmonary research community of the broad range of ethical issues that arise during manuscript preparation, review, publication, and dissemination of research results, and efforts that are in progress to minimize misconduct.